AI assistant
Sending…
Tango Therapeutics, Inc. — Director's Dealing 2020
Oct 7, 2020
32459_dirs_2020-10-07_cf317d7c-3aa7-4d7b-ba91-360f1cd57379.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BCTG Acquisition Corp. (BCTG)
CIK: 0001819133
Period of Report: 2020-10-06
Reporting Person: Avery James B (Director)
More from Tango Therapeutics, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Board/Management Information
2026
May 13
Board/Management Information
2026
May 8
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Board/Management Information
2026
Apr 15
Director's Dealing
2026
Mar 28
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Feb 27
Major Shareholding Notification
2026
Feb 17